Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A
- 19 March 2004
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 18 (7) , 914-916
- https://doi.org/10.1096/fj.03-1204fje
Abstract
Methionine adenosyltransferase (MAT) is an essential enzyme because it catalyzes the formation of S-adenosylmethionine (SAMe), the principal biological methyl donor. Of the two genes that encode MAT, MAT1A is mainly expressed in adult liver and MAT2A is expressed in all extrahepatic tissues. Mice lacking MAT1A have reduced hepatic SAMe content and spontaneously develop hepatocellular carcinoma. The current study examined the influence of chronic hepatic SAMe deficiency on liver regeneration. Despite having higher baseline hepatic staining for proliferating cell nuclear antigen, MAT1A knockout mice had impaired liver regeneration after partial hepatectomy (PH) as determined by bromodeoxyuridine incorporation. This can be explained by an inability to up-regulate cyclin D1 after PH in the knockout mice. Upstream signaling pathways involved in cyclin D1 activation include nuclear factor kappaB (NFkappaB), the c-Jun-N-terminal kinase (JNK), extracellular signal-regulated kinases (ERKs), and signal transducer and activator of transcription-3 (STAT-3). At baseline, JNK and ERK are more activated in the knockouts whereas NFkappaB and STAT-3 are similar to wild-type mice. Following PH, early activation of these pathways occurred, but although they remained increased in wild-type mice, c-jun and ERK phosphorylation fell progressively in the knockouts. Hepatic SAMe levels fell progressively following PH in wild-type mice but remained unchanged in the knockouts. In culture, MAT1A knockout hepatocytes have higher baseline DNA synthesis but failed to respond to the mitogenic effect of hepatocyte growth factor. Taken together, our findings define a critical role for SAMe in ERK signaling and cyclin D1 regulation during regeneration and suggest chronic hepatic SAMe depletion results in loss of responsiveness to mitogenic signals.Keywords
Funding Information
- National Institutes of Health (DK51719, AT1576, AA13847)
- Ministerio de Ciencia y Tecnología (2002‐00168)
- Ministerio de Ciencia y Tecnología (FIT‐090000‐2003‐109)
- Instituto de Salud Carlos III (G03/015, C03/02)
- National Institute on Alcohol Abuse and Alcoholism
This publication has 26 references indexed in Scilit:
- Uncoupling protein 2 in primary pain and temperature afferents of the spinal cordBrain Research, 2002
- Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1AThe FASEB Journal, 2002
- NO sensitizes rat hepatocytes to proliferation by modifying S-adenosylmethionine levelsGastroenterology, 2002
- S‐Adenosylmethionine: a control switch that regulates liver functionThe FASEB Journal, 2002
- Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferationProceedings of the National Academy of Sciences, 2001
- Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinomaPublished by Elsevier ,2000
- Effects of Oral S-Adenosyl-l-Methionine on Hepatic Glutathione in Patients with Liver DiseaseScandinavian Journal of Gastroenterology, 1989
- S -adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosisHepatology, 1988
- Biological Methylation: Selected AspectsAnnual Review of Biochemistry, 1975
- Rate of Disappearance From Plasma of Intravenously Administered Methionine in Patients With Liver DamageScience, 1947